Wells Fargo Sees Things Getting Interesting for Kate Spade (KATE); Affirms at 'Outperform'
- Stocks end near flat as investors assess earnings, data
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- Stocks have priced in much of the 2024 optimism - Wells Fargo
- Wall St closes lower; gold climbs amid economic, geopolitical crosswinds
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Alaska Airlines flights resume after being grounded over aircraft system issue
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
Kate Spade & Co. (KATE) on Watch Amid Chatter
November 14, 2016 9:44 AM EST(Updated)
Kate Spade & Co. (NYSE: KATE) was in focus amid chatter regarding takeover interest from Coach (NYSE: COH).
Earlier Caerus Investors sent a letter to Nancy Karch, Chairman of the Board of Directors of... More
JANA Partners Enters Kate Spade (KATE), Select Medical (SEM), Twitter (TWTR) (more...)
November 14, 2016 7:49 AM ESTJANA Partners released its 13F for the quarter ended September 30, 2016. Below is a summary:
New Stakes
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) new 149,252 share position
AdvancePierre Foods Holdings (NYSE: APFH) new 74,900 share position
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) new 52,890 share position
Dell Technologies Inc. (NYSE: DVMT) new 3,023,842 share position
Dermira (NASDAQ: DERM) new 149,457 share position
GW PHARM SP ADS (NASDAQ: GWPH) new 41,600 share position
Incyte Genomics, Inc. (NASDAQ: INCY) new 58,385 share position... More
UPDATE: Kate Spade (KATE) Receives Letter from Caerus Investors; Recommends Exploring Potential Sale
November 14, 2016 6:03 AM EST(Updated - November 14, 2016 6:05 AM EST)
Caerus Investors, a New York City-based asset management firm focused on investing in consumer-related equities has sent a constructive letter to Nancy Karch, Chairman of the Board of Directors of Kate Spade (NYSE: KATE) urging the Board to take steps to realize shareholder value by pursuing a sale of the company.Kate Spade & Co. (NYSE: KATE)
The full text of the letter follows:
Nancy KarchChairman of the BoardKate Spade & Co2 Park AveNew York, NY 100016
cc:... More